Search
for

    Glossary Androgenization

    process of developing male traits due to male hormones

    Androgenization refers to the process by which the body develops male characteristics due to the influence of androgens, which are male sex hormones like testosterone. This can affect various aspects of the body, including hair growth patterns, voice deepening, and muscle mass. In a medical context, excessive androgenization can lead to conditions such as hirsutism (excessive hair growth) or androgenic alopecia (male-pattern baldness).

    Sort by

    Research 30 of 182

    1. Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception 2004 · 17 citations
    2. Androgenization in women : acne, seborrhoea, androgenetic alopecia and hirsutism : lectures and discussions of a symposium, Berlin, 23rd-24th February 1979 Excerpta Medica , sole distributors for the USA and Canada, Elsevier North-Holland eBooks · 1980
    3. Anti-Müllerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome European Journal of Endocrinology · 2011 · 12 citations
    4. Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome Endocrinology · 2018 · 6 citations
    5. Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia) Journal für Kardiologie (Krause & Pachernegg GmbH) · 2010 · 8 citations
    6. [Hormones--underestimated problem in dermatology. Part I. Diseases connected with excessive androgenisation]. PubMed · 2002
    7. Diffuse female hair loss: are androgens necessary? British Journal of Dermatology · 1999 · 110 citations
    8. Finasteride as a therapy for hidradenitis suppurativa British Journal of Dermatology · 1999 · 50 citations
    9. Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin Annals of Oncology · 2003 · 15 citations
    10. Androgenisierung Gynäkologische Endokrinologie · 2012 · 1 citations
    11. Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain Annals of Medicine · 2025
    12. [G-proteins, receptor signal transduction, and growth hormone secretion]. PubMed · 1993
    13. Non-Contraceptive Benefits of Oral Hormonal Contraceptives 2012 · 83 citations
    14. Transient scrotal hair growth in infancy Postgraduate Medical Journal · 2005 · 11 citations
    15. Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies The Journal of Clinical Endocrinology and Metabolism · 2006 · 253 citations
    16. Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie Journal für Kardiologie (Krause & Pachernegg GmbH) · 2012 · 2 citations
    17. Androgenisierung: Diagnostik und Therapie – Akne vulgaris, Hirsutismus, female pattern hair loss Springer eBooks · 2022
    18. FRI-02 FROM GIRLS TO BOYS TO OLDER MEN, THE INTERESTING TALE OF THE GUEVEDOCES AND 5-ALPHA REDUCTASE INHIBITORS The Journal of Urology · 2016
    19. Pharmacological basis for clinical use of antiandrogens 1983 · 24 citations
    20. SAT384 Is This A Case of Androgen-Secreting Endometrial Cancer in A Postmenopausal Woman? Journal of the Endocrine Society · 2023
    21. PHARMACOLOGICAL BASIS FOR CLINICAL USE OF ANTIANDROGENS Elsevier eBooks · 1983
    22. Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up – Endocrine Abstracts · 2022
    23. Hyperandrogenism in Adolescent Girls Endocrine development · 2012 · 14 citations
    24. The case of the felted wig Acta dermato-venereologica · 1983 · 1 citations
    25. Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures Pharmaceutical medicine · 2024
    26. Polycystic ovary syndrome Nature Reviews Disease Primers · 2016 · 883 citations
    27. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia Journal of Nutrition Health & Aging · 2013 · 211 citations
    28. Obesity and the skin British Journal of Dermatology · 2011 · 128 citations
    29. Diagnosis of hyperandrogenism: clinical criteria Best Practice & Research Clinical Endocrinology & Metabolism · 2006 · 85 citations
    30. Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism European Journal of Clinical Investigation · 2011 · 39 citations